FDA has released a proposed rule to govern “gluten-free” labeling on food products. Congress required FDA to begin rulemaking on the issue of “gluten-free” claims as part of the Food Allergen Labeling and Consumer Protection Act of 2004 (“FALCPA”). FALCPA directed FDA to issue its proposed rule by August 2006 with a final rule to be implemented no later than August 2008.
The proposed rule will be published in the Federal Register on January 23 and the comment period will be open for 90 days.
If you would like additional information, please contact a Food Industry Team representative or visit the FDA’s Web site.
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."